Company Filing History:
Years Active: 2000
Title: Greg Wolgamot: Innovator in Retroviral Packaging Cell Technology
Introduction
Greg Wolgamot is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of gene therapy through his innovative work on retroviral packaging cell lines. His research focuses on developing tools that enhance gene transfer capabilities, which are crucial for advancing medical treatments.
Latest Patents
Greg Wolgamot holds a patent for "Mus dunni endogenous retroviral packaging cell lines." This invention involves retroviral packaging cells that produce replication-defective retroviral particles. These particles are capable of binding to Mus dunni endogenous virus retroviral receptors on target cells. This technology is particularly useful in gene transfer and gene therapy applications. The packaging cell utilizes a vector encoding a M. dunni retroviral Env protein, enabling the production of retroviral particles at high titer.
Career Highlights
Greg is affiliated with the Fred Hutchinson Cancer Center, where he conducts his research. His work at this esteemed institution has allowed him to collaborate with leading scientists and contribute to groundbreaking advancements in cancer treatment and gene therapy.
Collaborations
Some of his notable coworkers include A Dusty Miller and Lynn Bonham. Their collaborative efforts have furthered the research and development of innovative solutions in the field of retroviral technology.
Conclusion
Greg Wolgamot's contributions to retroviral packaging cell technology exemplify the impact of innovation in gene therapy. His work continues to pave the way for advancements in medical science and treatment options.